APA
Pericay Pijaume C., Escudero Emperador P., Bastús Piulats R., Campos Cervera J. M., Esquerdo Galiana G., Gallén Castillo M., Alfaro Gamero J., Dotor Navarro E., Pisa Gatell A., Guasch Jordán I. & Saigí Grau E. (20110509). Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Chicago
Pericay Pijaume Carles, Escudero Emperador Pilar, Bastús Piulats Román, Campos Cervera Juan Manuel, Esquerdo Galiana Gaspar, Gallén Castillo Manuel, Alfaro Gamero Jordi, Dotor Navarro Emma, Pisa Gatell Aleydis, Guasch Jordán Inmaculada and Saigí Grau Eugeni. 20110509. Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Harvard
Pericay Pijaume C., Escudero Emperador P., Bastús Piulats R., Campos Cervera J. M., Esquerdo Galiana G., Gallén Castillo M., Alfaro Gamero J., Dotor Navarro E., Pisa Gatell A., Guasch Jordán I. and Saigí Grau E. (20110509). Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
MLA
Pericay Pijaume Carles, Escudero Emperador Pilar, Bastús Piulats Román, Campos Cervera Juan Manuel, Esquerdo Galiana Gaspar, Gallén Castillo Manuel, Alfaro Gamero Jordi, Dotor Navarro Emma, Pisa Gatell Aleydis, Guasch Jordán Inmaculada and Saigí Grau Eugeni. Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20110509.